当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第27期 > 正文
编号:12158831
进展期胃癌术中行区域性缓释化疗的安全性评价(1)
http://www.100md.com 2011年9月25日 何行昌
第1页

    参见附件(2792KB,2页)。

     【摘要】目的探讨进展期胃癌术中腹腔内行区域性植入5氟尿嘧啶缓释化疗的临床疗效及用药安全进行分析评价。方法将60例进展期胃癌患者均进行手术根治切除术后并随机分为两组,治疗组:30例患者给予术中行区域性缓释化疗;对照组30例患者与治疗组患者术后均进行常规全身化疗,并对其两组患者治疗后临床疗效进行疗效评价及安全性评价。结果疗效判定治疗组:完全缓解8例占267%、部分缓解11例占367%、疾病稳定7例占233%、疾病进展4例占133%。对照组:完全缓解5例占17%、部分缓解9例占300%、疾病稳定11例占367%、疾病进展5例占167%。两组患者在治疗后腹腔相关并发症与化疗毒副作用无显著差异。结论进展期胃癌术中腹腔内行区域性植入5氟尿嘧啶缓释化疗,患者耐受性良好,用药后临床疗效增加而未见明显的全身、局部不良反应。

    【关键词】进展期胃癌;区域缓释化疗;5氟尿嘧啶缓释剂;疗效评价;不良反应

    Advanced gastric cancer intraoperative regional safety evaluation of sustainedrelease chemotherapyHE Xingchang.Departmetn of General Surgery The First Peoples Hospital of Shangqiu city 476100,China

    【Abstract】ObjectiveTo discuss advanced gastric cancer implanted in the abdominal cavity of regional experts 5Fluorouracil chemotherapy efficacy and sustainedrelease drug safety analysis and evaluationMethods60 cases of advanced gastric cancer patients underwent radical surgical resection were randomly divided into treatment groups:30 patients were treated with intraoperative regional slowrelease chemotherapy,control group of 30 patients with treatment group patientsare routine chemotherapy, and two groups of patients after their clinical efficacy evaluation and safety evaluationResultsDetermine the efficacy of the treatment groups:complete remission in 8 cases accounted for 267%, partial response 11 cases accounted for 367%, seven cases of stable disease 233%, disease progression was four cases (133%)Control group:5 cases were (17%) complete remission, partial remission in 9 cases accounted for 300%, stable disease 11 cases accounted for 367%, disease progression, five cases of 167%Two groups of patients after abdominalrelated complications in the treatment of chemotherapy side effects with no significant differenceConclusionAdvanced gastric cancer surgery in the abdominal cavity implantation of regional experts 5Fluorouracil sustainedrelease chemotherapy, the patient is well tolerated, clinical efficacy after treatment no significant increase in systemic and local adverse reactions.

    【Key words】Advanced gastric cancer; Regional release chemotherapy; 5Fluorouracil release agent; Evaluation; Adverse reactions ......

您现在查看是摘要介绍页,详见PDF附件(2792KB,2页)